<DOC>
	<DOCNO>NCT02787603</DOCNO>
	<brief_summary>Introduction : Acute Heart Failure frequently decompensated pulmonary infection , diagnosis pulmonary infection sometimes difficult patient due similar signal clinical symptom pathology . Furthermore , possible diagnosis pulmonary infection , physician may difficult determine etiology delay antibiotic therapy . Procalcitonin ( PCT ) use like biomarker determine period use antibiotic patient acute respiratory infection . It specific bacterial infection show marker severity infection may help determine interruption period antibiotic therapy safety way patient . Aim : Evaluate level PCT relate interruption antibiotic patient decompensated acute heart failure ( DAHF ) suspect bacterial pulmonary infection . Methods : In pilot project include around 100 patient , randomize two group : group A ( PCT level may guide interruption antibiotic day 5 ) group B ( antibiotic period determine physician without knowledge PCT level ) . Will collect laboratorial clinical data day 0,3 5 . Both group compare evaluate PCT level total period antibiotic therapy , hospitalization readmission 30 day . This study determine sensibility/specificity PCT patient DAHF .</brief_summary>
	<brief_title>Procalcitonin Early Antibiotic Interruption Patient With Bacterial Pulmonary infeCtion Acute Heart Failure</brief_title>
	<detailed_description>It single-center study , randomize , control , prospective cohort interventional blind . DAHF diagnosis consider symptom , physical examination , x ray image method BNP ou NTproBNP level . Pulmonary infection diagnosis `` Infectious Disease Society America / American Thoracic Society Consensus Guidelines Management Community-Acquired Pneumonia Adults '' criterion , include fever , cough , sputum , pleuritic pain , positive pulmonary image physical examination . PCT NTproBNP level measure miniVIDAS® ( bioMérieux Clinical Diagnostics , France ) . Statistics include descriptive analysis . Parametric data evaluate use T test non parametric data Mann-Whitney-Wilcoxon test . Multivariative analysis relate diagnosis , mortality morbidity perform Cox regression model . Sensibility specificity calculate ROC curve . Statistical significancy consider p &lt; 0.05 .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>DAHF diagnosis suspect pulmonary infection BNP ≥ 500 pg/mL NTproBNP ≥ 450 pg/mL patient 50 year old . BNP ≥ 500 pg/mL NTproBNP ≥ 900 pg/mL patient 51 75 year old . BNP ≥ 500 pg/mL NTproBNP ≥ 1800 pg/mL patient older 75 year . Antibiotic use ( oral endovenous ) last 15 day ; Acute coronary syndrome ; Creatinine &gt; 3,0 mg/dL hemodialysis ; Pregnancy ; Second suspectec infection ; Suspected pulmonary thromboembolism ; cancer ; myocarditis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>